U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
2175121751A Phase 2 Study to Evaluate the Safety and Efficacy of CB-03-01 Solution, a Comparator Solution and Vehicle Solution in Males With Androgenetic AlopeciaRecruitingNo Results AvailableAndrogenetic AlopeciaDrug: CB-03-01 solution|Drug: Minoxidil Solution 5%|Drug: Placebo solutionhttps://ClinicalTrials.gov/show/NCT02279823
2175221752Attitudes About Organ TransplantationRecruitingNo Results AvailableTransplantation, OrganBehavioral: surveyhttps://ClinicalTrials.gov/show/NCT02279810
2175321753Bone Marrow DonationRecruitingNo Results AvailableBone Marrow DonationBehavioral: surveyhttps://ClinicalTrials.gov/show/NCT02279797
2175421754Drug Eluting Balloon in peripherAl inTErvention for Below-The-Knee Arteries With Freeway and LutonixRecruitingNo Results AvailablePeripheral Artery DiseaseDevice: Freeway PTA|Device: Lutonix PTAhttps://ClinicalTrials.gov/show/NCT02279784
2175521755Transanal Reinforcement of Low Rectal Anastomosis in Rectal Cancer SurgeryNot yet recruitingNo Results AvailableRectal CancerProcedure: transanal anastomotic reinforcement|Procedure: protective ileostomy group|Device: a circular anal dilator (CAD)https://ClinicalTrials.gov/show/NCT02279771
2175621756A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine TumorsRecruitingNo Results AvailableWell-differentiated Neuroendocrine TumorsDrug: Metforminhttps://ClinicalTrials.gov/show/NCT02279758
2175721757Long Term Safety and Efficacy of APD811 in Pulmonary Arterial HypertensionRecruitingNo Results AvailablePulmonary Arterial HypertensionDrug: APD811https://ClinicalTrials.gov/show/NCT02279745
2175821758Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Plus Paclitaxel and Carboplatin Versus Placebo Plus Paclitaxel and CarboplatinRecruitingNo Results AvailableLung Cancer (NSCLC)Biological: Paclitaxel|Biological: Carboplatin|Biological: Ipilimumab|Other: Placebohttps://ClinicalTrials.gov/show/NCT02279732
2175921759A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular CarcinomaRecruitingNo Results AvailableHepatocellular CarcinomaDrug: BBI608|Drug: BBI503|Drug: Sorafenibhttps://ClinicalTrials.gov/show/NCT02279719
2176021760Korean Linguistic Adaptation of Rhinitis Controlled Assessment TestRecruitingNo Results AvailableRhinitisOther: questionnairehttps://ClinicalTrials.gov/show/NCT02279706
2176121761Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate CancerRecruitingNo Results AvailableProstate CancerOther: CBCT|Other: fiducial marker (kV imaging)|Radiation: IGRT Associated With IMRThttps://ClinicalTrials.gov/show/NCT02279693
2176221762Associative Memory in Adults With an Autism Spectrum DisorderRecruitingNo Results AvailableAutistic DisorderDevice: Electroencephalography|Behavioral: Neuropsychological assesmentshttps://ClinicalTrials.gov/show/NCT02279680
2176321763Single-dose Pharmacokinetics and Relative Bioavailability of an Oral Suspension and Two Tablet Formulations of BIA 2-093CompletedHas ResultsEpilepsyDrug: BIA 2-093|Drug: BIA 2-093|Drug: BIA 2-093https://ClinicalTrials.gov/show/NCT02279667
2176421764Registry Study for Individuals With Del 5q Low or Intermediate-1 Risk MDSRecruitingNo Results AvailableMyelodysplastic Syndrome (MDS)Drug: Lenalidomidehttps://ClinicalTrials.gov/show/NCT02279654
2176521765RDEA3170 and Allopurinol Combination Study in Gout SubjectsCompletedNo Results AvailableGoutDrug: RDEA3170 10 mg|Drug: allopurinol 300 mghttps://ClinicalTrials.gov/show/NCT02279641
2176621766Continuous Pre-uterine Wound Infiltration Versus Intrathecal Morphine for Postoperative Analgesia After Cesarean SectionRecruitingNo Results AvailablePostoperative PainDrug: Ropivacaine|Drug: Morphinehttps://ClinicalTrials.gov/show/NCT02279628
2176721767Efficacy And Safety Of Combination Therapy For Treatment Of Overactive Bladder In Male Patients With Benign Prostatic Hyperplasia.Not yet recruitingNo Results AvailableOveractive Bladder|Benign Prostatic HyperplasiaDrug: Mirabegron|Drug: Tamsulosinhttps://ClinicalTrials.gov/show/NCT02279615
2176821768Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 StudyEnrolling by invitationNo Results AvailableGastrointestinal Neuroendocrine TumorsDrug: fosbretabulinhttps://ClinicalTrials.gov/show/NCT02279602
2176921769Open Randomized Trial Evaluating Four Anti-pneumococcal Vaccine Strategies With Fractionated Doses of Non Conjugate Polysaccharide Vaccine to Prevent Hyporesponse in Healthy VolunteersActive, not recruitingNo Results AvailablePneumococcal InfectionBiological: Pneumo 23® 0,5|Biological: Pneumo 23® 0,1|Biological: Prevenar13® 0,5https://ClinicalTrials.gov/show/NCT02279589
2177021770Study With Pazopanib and Weekly Paclitaxel in Penile Carcinoma (PAZOPEN-SOGUG)Not yet recruitingNo Results AvailablePenile Squamous Cell Carcinoma Stage IVDrug: Pazopanib|Drug: Paclitaxelhttps://ClinicalTrials.gov/show/NCT02279576
2177121771A Study Comparing the Bioequivalence of Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (Apotex, Inc.) to That of Dymista™ Nasal Spray (Meda Pharmaceuticals, Inc.) in the Treatment of Seasonal Allergic RhinitisEnrolling by invitationNo Results AvailableSeasonal Allergic RhinitisDrug: Azelastine HCl and Fluticasone Propionate Nasal Spray, 137 µg/50 µg per spray|Drug: Dymista™ Nasal Spray|Drug: Placebohttps://ClinicalTrials.gov/show/NCT02279563
2177221772Institutional Registry of Hip Fracture in the ElderlyRecruitingNo Results AvailableHip Fracturehttps://ClinicalTrials.gov/show/NCT02279550
2177321773Real Life of Aflibercept In FraNce: oBservatiOnnal Study in Wet AMDActive, not recruitingNo Results AvailableWet Macular DegenerationDrug: Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)https://ClinicalTrials.gov/show/NCT02279537
2177421774A Clinical Trial to Evaluate the Efficacy and Safety of Two Aramchol Doses Versus Placebo in Patients With NASHRecruitingNo Results AvailableFatty LiverDrug: Aramcholhttps://ClinicalTrials.gov/show/NCT02279524
2177521775ATP in Alzheimer DiseaseRecruitingNo Results AvailableAlzheimer's DiseaseDrug: ADENOSINE TRIPHOSPHATE|Drug: PLACEBOhttps://ClinicalTrials.gov/show/NCT02279511
2177621776SOLUTION: Study of Oral Liprotamase Unit-Matched Therapy Of Non-Porcine Origin in Patients With Cystic FibrosisNot yet recruitingNo Results AvailableExocrine Pancreatic Insufficiency|Cystic FibrosisDrug: Liprotamase|Drug: porcine (pig) PERThttps://ClinicalTrials.gov/show/NCT02279498
2177721777A Study to Demonstrate Bioequivalence Between a 12-mg Dose of an Oral Suspension Formulation of Perampanel and a 12-mg Tablet Formulation of Perampanel Under Fasted and Fed Conditions in Healthy SubjectsCompletedNo Results AvailableHealthy SubjectsDrug: Perampanelhttps://ClinicalTrials.gov/show/NCT02279485
2177821778Optical Coherence Tomography Quantitative Analysis of Changes in Anterior Chamber After Laser Peripheral LridotomyRecruitingNo Results AvailablePrimary Angle Closure GlaucomaProcedure: Laserex Tango Nd:YAG, Ellex-SuperQ Medical, Australiahttps://ClinicalTrials.gov/show/NCT02279472
2177921779Dual-Energy CT in Patients With Head and Neck Squamous Cell CarcinomasNot yet recruitingNo Results AvailableHead and Neck Squamous Cell Carcinomahttps://ClinicalTrials.gov/show/NCT02279459
2178021780Development of a Validated Chart for Intermediate Vision AssessmentRecruitingNo Results AvailableMyopia|Hyperopia|Presbyopia|AstigmatismOther: Intermediate Visual acuity (IVA) assessmenthttps://ClinicalTrials.gov/show/NCT02279446

* Görseller ve İçerik tekif hakkına sahip olabilir